Focused ultrasound helped deliver microRNAs that targeted multiple glioblastoma genes and improved outcomes in animal models. A treatment aimed at glioblastoma must first cross one of the body’s most selective defenses: the blood-brain barrier. Researchers at the University of Virginia…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.